Novartis Cosentyx Trial Shows Efficacy In Patients With Stiff Joints And Muscle Pain

Why is Meta cutting 600 AI jobs? How will US export curbs affect China? What caused Netflix’s latest earnings miss? Why is Beyond Meat stock surging again? How is Amazon using AI in delivery? What impact will NHL prediction market deal have? Why did Texas Instruments stock tumble?

Novartis Cosentyx Trial Shows Efficacy In Patients With Stiff Joints And Muscle Pain

benzinga.com/news/health-care/25/10/48363377/novartis-cosentyx-trial-shows-efficacy-in-patients-with-stiff-joints-and-muscle-pain

Novartis AG (NYSE:NVS) on Wednesday shared topline data from the Phase 3 REPLENISH trial of Cosentyx in patients with polymyalgia rheumatica.
NVS is trading near recent highs. Track the action here
Polymyalgia rheumatica is the second most common inflammatory rheumatic disease in adults…

This story appeared on benzinga.com, 2025-10-22 18:35:12.